Increased differentiation of dermal mast cells in mice lacking the Mpl gene

Stem Cells and Development

Volumn 18, Issue 7, 2009, Pages 1081-1092

  Ghinassi, Barbara ^a,b   Zingariello, Maria ^a,b   Martelli, Fabrizio ^a   Lorenzini, Rodolfo ^c   Vannucchi, Alessandro M ^d   Rana, Rosa Alba ^b   Nishikawa, Mitsuo ^c,e   Migliaccio, Giovanni ^f   Mascarenhas, John ^h   Migliaccio, Anna Rita ^a,g,h  

^a Department of Hematology Oncology and Molecular Medicine   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c Department of Quality and Safety of Animal Experimentation ^*

^d UNIVERSITY OF FLORENCE   (Italy)

^e Pharmaceutical Research Laboratory   (Japan)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^g Myeloproliferative Disorders Research Consortium (MPD RC)   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MPL; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; INTESTINE; MALE; MAST CELL; MOUSE; MUCOSA CELL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROSA; SKIN CELL; SPLEEN; STEM CELL; THROMBOCYTE COUNT;

ANIMALS; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; DERMIS; HEMATOPOIETIC STEM CELLS; INTESTINES; MAST CELLS; MICE; MICE, MUTANT STRAINS; ORGAN SPECIFICITY; PERITONEAL CAVITY; RECEPTORS, THROMBOPOIETIN; SPLEEN; THROMBOPOIETIN;

MUS;

EID: 70349431426     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0323     Document Type: Article

References (58)

1. Galli SJ and M Tsai. (2008). Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci 49:7-19.
2. Metcalfe DD. (2008). Mast cells and mastocytosis. Blood 112:946-956.
3. Kitamura Y, M Yokoyama, H Matsuda, T Ohno and KJ Mori. (1981). Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes. Nature 291:159-160.
4. Gurish MF and KF Austen. (2001). The diverse roles of mast cells. J Exp Med 194:F1-F5.
5. Galli SJ, S Nakae and M Tsai. (2005). Mast cells in the development of adaptive immune responses. Nat Immunol 6:135-142.
6. Rodewald HR, M Dessing, AM Dvorak and SJ Galli. (1996). Identification of a committed precursor for the mast cell lineage. Science 271:818-822.
7. Chen CC, MA Grimbaldeston, M Tsai, IL Weissman and SJ Galli. (2005). Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci USA 102:11408-11413.
8. Kitamura Y and A Ito. (2005). Mast-cell committed progenitors. Proc Natl Acad Sci USA 102:11129-11130.
9. Arinobu Y, H Iwasaki, MF Gurish, S Mizuno, H Shigematsu, H Ozawa, DG Tenen, KF Austen and K Akashi. (2005). Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci USA 102:18105-18110.
10. Jamur MC, AC Grodzki, EH Berenstein, MM Hamawy, RP Siraganian and C Oliver. (2005). Identification and characterization of undifferentiated mast cells in mouse bone marrow. Blood 105:4282-4289.
11. Pejler G, M Abrink, M Ringvall and S Wernersson. (2007). Mast cell proteases. Adv Immunol 95:167-255.
12. Takemoto CM, YN Lee, AG Jegga, D Zablocki, S Brandal, A Shahlee, S Huang, Y Ye, S Gowrisankar, J Hunyh and MA McDevitt. (2008). Mast cell transcriptional networks. Blood Cells Mol Dis 41(1):82-90.
13. Reynolds DS, RL Stevens, WS Lane, MH Carr, KF Austen and WE Serafin. (1990). Different mouse mast cell populations express various combinations of at least six distinct mast cell serine proteases. Proc Natl Acad Sci USA 87:3230-3234.
14. Yamada Y, N Itano, K Hata, M Ueda and K Kimata. (2004). Differential regulation by IL-1beta and EGF of expression of three different hyaluronan synthases in oral mucosal epithelial cells and fibroblasts and dermal fi broblasts: quantitative analysis using real-time RT-PCR. J Invest Dermatol 122: 631-639.
15. Kaushansky K and JG Drachman. (2002). The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 21:3359-3367.
16. Migliaccio AR, RA Rana, M Sanchez, R Lorenzini, L Centurione, L Bianchi, AM Vannucchi, G Migliaccio and SH Orkin. (2003). GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med 197:281-296.
17. Shivdasani RA, Y Fujiwara, MA McDevitt and Orkin SH. (1997). A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 16:3965-3973.
18. Harigae H, S Takahashi, N Suwabe, H Ohtsu, L Gu, Z Yang, FY Tsai, Y Kitamura, JD Engel and M Yamamoto (1998). Differential roles of GATA-1 and GATA-2 in growth and differentiation of mast cells. Genes Cells 3:39-50.
19. Vannucchi AM, L Bianchi, F Paoletti, A Pancrazi, E Torre, M Nishikawa, M Zingariello, A Di Baldassarre, RA Rana, R Lorenzini, E Alfani, G Migliaccio and AR Migliaccio. (2005). A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-?1 in the development of myelofi brosis. Blood 105:3493-3501.
20. Migliaccio AR, RA Rana, AM Vannucchi and FA Manzoli. (2007). Role of Thrombopoietin in mast cell differentiation. Ann N Y Acad Sci 1106:152-174.
21. Sawai N, K Koike, HH Mwamtemi, T Kinoshita, Y. Kurokawa, K Sakashita, T Higuchi, K Takeuchi, M Shiohara, T Kamijo, S Ito, T Kato, H Miyazaki, T Yamashita and A Komiyama. (1999). Thrombopoietin augments stem cell factor dependent growth of human mast cells from bone marrow multipotential hematopoietic progenitors. Blood 93:3703-3712.
22. Kirshenbaum AS, C Akin, JP Goff and DD Metcalfe. (2005). Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT(CD117)low/ MPL(CD110)+ human mast cells from hematopoietic progenitor cells. Exp Hematol 33:413-421
23. Yoshikubo T, T Inoue, M Noguchi and H Okabe. (2006). Differentiation and maintenance of mast cells from CD34(+) human cord blood cells. Exp Hematol 34:320-329.
24. Kaushansky K. (2003). Etiology of the myeloproliferative disorders: the role of thrombopoietin. Semin Hematol 40:6-9.
25. McIntosh B and K Kaushansky. (2008). Transcriptional regulation by bone marrow thrombopoietin by platelet proteins. Exp Hematol 36(7):799-806.
26. Yoshihara H, F Arai, K Hosokawa, T Hagiwara, K Takubo, Y Nakamura, Y Gomei, H Iwasaki, S Matsuoka, K Mihamoto, H Miyasaki, T Takahashi and T Suda. (2007). Trombopoietin/ MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 1(6): 685-696.
27. Martelli F, B Ghinassi, R Lorenzini, AM Vannucchi, RA Rana, M Nishikawa, S Partamian and AR Migliaccio. (2008). Thrombopoietin Inhibits Murine Mast Cell Differentiation. Stem Cells 26(4):912-919.
28. Alexander WS, AW Roberts, NA Nicola, R Li and D Metcalfe. (1996) Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 87:2162-2170.
29. Ghinassi B, M Sanchez, F Martelli, G Amabile, AM Vannucchi, G Migliaccio, SH Orkin and AR Migliaccio. (2007). The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic- erythroid progenitor. Blood 109:1460-1471.
30. Migliaccio AR, F Martelli, M Verrucci, G Migliaccio, AM Vannucchi, H Ni, M Xu, Y Jiang, B Nakamoto, T Papayannopoulou and R Hoffman. (2008). Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease. Exp Hematol 36:158-171.
31. Luc S, K Anderson, S Kharazi, N Buza-Vidas, C Böiers, CT Jensen, Z Ma, L Wittmann and SEW Jacobsen. (2008) Down-regulation of Mpl marks the transition to lymphoid-primed multipotent progenitors with gradual loss of granulocyte-monocyte potential. Blood 111:3424-3434.
32. Pennock JL and RK Grencis. (2004). In vivo exit of c-kit+/ CD49d(hi)/beta7+ mucosal mast cell precursors from the bone marrow following infection with the intestinal nematode Trichinella spiralis. Blood 103:2655-2660.
33. Stevens RL, DS Friend, HP McNeil, V Shiller, N Ghildyal and KF Austen. (1994). Strain-specific and tissue-specifi c expression of mouse mast cell secretory granule proteases. Proc Natl Acad Sci USA 91:128-132.
34. Qian S, F Fu, W Li, Q Chen and FJ de Sauvage. (1998). Primary role of the liver in thrombopoietin production shown by tissue-specific knockout. Blood 92:2189-2191.
35. Sungaran R, OT Chisholm, Markovic B, LM Khachigian, Y Tanaka and BH Chong. (2000). The role of platelet alpha-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells. Blood 95:3094-3101.
36. Emmons RV, DM Reid, RL Cohen, G Meng, NS Young, CE Dunbar and NR Shulman. (1996). Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87:4068-4071.
37. Cardier JE and J Dempsey. (1998). Thrombopoietin and its receptor, c-mpl, are constitutively expressed by mouse liver endothelial cells: evidence of thrombopoietin as a growth factor for liver endothelial cells. Blood 91:923-929.
38. Tsai FY and SH Orkin. (1997). Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89:3636-3643.
39. Jippo T, H Mizuno, Z Xu, S Nomura, M Yamamoto and Y Kitamura. (1996). Abundant expression of transcription factor GATA-2 in proliferating but not in differentiated mast cells in tissues of mice: demonstration by in situ hybridization. Blood 87:993-998.
40. Zon LI, MF Gurish, RL Stevens, C Mather, DS Reynolds, KF Austen and SH Orkin. (1991). GATA-binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene. J Biol Chem 266:22948-22953.
41. Nishiyama C, T Yokota, K Okumura and C Ra. (1999). The transcription factors Elf-1 and GATA-1 bind to cell-specifi c enhancer elements of human high-affinity IgE receptor alpha-chain gene. J Immunol 163:623-630.
42. Maeda K, C Nishiyama, T Tokura, Y Akizawa, M Nishiyama, H Ogawa, K Okumura and C Ra. (2003). Regulation of cell type-specific mouse FceRI beta-chain gene expression by GATA-1 via four GATA motifs in the promoter. J Immunol 170:334-340.
43. Morii E, T Jippo, T Tsujimura, K Hashimoto, DK Kim, YM Lee, H Ogihara, K Tsujino, HM Kim and Y Kitamura. (1997). Abnormal expression of mouse mast cell protease 5 gene in cultured mast cells derived from mutant mi/mi mice. Blood 90:3057-3066.
44. Adams JM and S Cory. (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326.
45. Lorentz A, D Schuppan, A Gebert, MP Manns and SC Bischoff. (2002). Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins. Blood 99:966-972.
46. Townsend JM, GP Fallon, JD Matthews, P Smith, EH Jolin and NA Mckenzie. (2002). IL-9 deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13:573-583.
47. Qi JC, J Wang, S Mandadi, K Tanaka, BD Roufogalis, MC Madigan, K Lai, F Yan, BH Chong, RL Stevens and A Steven. (2006) Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor. Blood 107:135-142.
48. Shiohara M and K Koike. (2005) Regulation of mast cell development. Chem Immunol Allergy 87:1-21.
49. Finotto S, YA Mekori and DD Metcalfe. (1997). Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J Clin Invest 99:1721-1728.
50. Yamaguchi M, K Hirai, A Komiya, M Miyamasu, Y Furumoto, R Teshima, K Ohta, Y Morita, SJ Galli, C Ra and K Yamamoto. (2001). Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone. Int Immunol 13:843-851.
51. Levin J, FC Levin, DF Hull 3rd and DG Penington. (1982). The effects of thrombopoietin on megakaryocytes-cfc, megakaryocytes, and thrombopoiesis, with studies of ploidy and platelet size. Blood 60:989-998.
52. Fox N, G Priestly, T Papayannopoulou and K Kaushansky. (2002). Thrombopoietin expands hematopoietic stem cells after transplantation. J Clin Invest 110:389-394.
53. Fielder PJ, P Hass, M Nagel, E Stefanich, R Widmer, GL Bennet, G-A Keller, FJ de Sauvage and D Eaton. (1997). Human platelets as a model for the binding and degradation of thrombopoietin. Blood 89:2782-2788.
54. Li B, H Pan, JC Winkelmann and W Dai. (1996). Thrombopoietin and its alternatively spliced form are expressed in human amygdala and hippocampus. Blood 87:5382-5384.
55. Ehrenreich H, M Hasselblatt, F Knerlich, N von Ahsen, S Jacob, S Sperling, H Woldt, K Vehmeyer, KA Nave and AL Sirén. (2005). A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci USA 102:862-867.
56. Qian H, N Buza-Vidas, CD Hyland, CT Jensen, J Antonchuk, R Månsson, LA Thoren, M Ekblom, WS Alexander and SEW Jacobsen. (2007). Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 1:671-684.
57. Guerriero A, L Worford, HK Holland, GR Guo, K Sheehan and EK Waller. (1997). Thrombopoietin is synthesized by bone marrow stromal cells. Blood 90:3444-3455.
58. Sungaran R, B Markovic and BH Chong. (1997). Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 89:101-107.